Close Menu

NEW YORK (GenomeWeb) – BioMark Diagnostics today announced it is partnering with The Metabolomics Innovation Centre on cancer research. 

The deal augments BioMark's efforts to discover, validate, and translate metabolomics-based diagnostic tests for early cancer detection, the Vancouver, British Columbia-based firm said, adding it "complements" its planned research into lung, prostate, breast, and colon cancer.  

In collaboration with TMIC, BioMark plans to develop novel point-of-care diagnostic tests. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

An Associated Press report says China refrained from releasing the SARS-CoV-2 genome for more than a week in January, frustrating the World Health Organization.

The Lancet and the New England Journal of Medicine have issued expressions of concern regarding the data used in two COVID-19 papers, the New York Times reports. 

Researchers have sequenced the genome of the mayfly, garnering insight into how insects evolved wings, Science reports.

In Genome Research this week: gene expression in primate brain regions, inversions and breakpoint inverted repeats in the human genome, and more.